entertainment -WSS

entertainment

author：explore 2025-09-14 21:59:51 - browse：4889

JOSEPH PREZIOSO/AFP via Getty Images

Late-stage trial results for a pain medication developed by Vertex Pharmaceuticals reinforced experts’ sense that the drug was both safe and offered modest pain relief. But the findings also prompted fresh debate on Tuesday about how widely used the therapy would be should it win regulatory approval.

The company reported that its small molecule drug, VX-548, outperformed placebo in a pair of pain relief trials that recruited patients who had gotten an abdominoplasty (tummy tuck) or bunion surgery. The study also found that the drug was generally safe, with fewer patients on the medication reporting adverse events than those who had taken a placebo. But there was a catch: VX-548 didn’t outperform a combination of acetaminophen and the opioid hydrocodone, a key secondary endpoint. And in the bunionectomy study, the opioid comparator beat VX-548 on pain relief.

“While this study was not explicitly designed to test VX-548 vs. the opioid comparator, this may complicate the prescribing decision in the acute setting, where patients often take a short course of treatment and efficacy is a primary consideration,” Stifel market analyst Paul Matteis wrote in a note to investors, adding that results from three Phase 3 studies were positive overall.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Medicare Advantage insurers pressure Biden for bigger payments

WSS

'Patient friction coefficient' can gauge a clinical trial's patient burden

ER docs worry over extreme heat as a 'mass casualty event'

For BCIs, commercial hurdles may be bigger than scientific ones

CRISPR technology availability, affordability needs to be expanded

Readout Newsletter: Illumina, CRISPR, Regeneron

Biotech investment managers search for lucrative opportunities

hotspot

entertainment

leisure time

Jerome Adams on the need for new antivirals for Covid

Bring on the sabbaticals for nurses

Malaria cases in Florida and Texas: Here’s what you need to know

OTC birth control: A brief history of over the counter pill design

Medicare proposal to cover medical devices draws a mixed reaction

A cyberattack has disrupted hospitals and health care in several states

How one medical school became remarkably diverse

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

DIEP, the 'gold standard' of breast reconstruction, is under threat

The drug industry sees a key ally in the Senate prevail

entertainment

Medicare Advantage insurers pressure Biden for bigger payments

What Kate Middleton's cancer revelation might teach the world

ER docs worry over extreme heat as a 'mass casualty event'

U.K. officials, researchers try to ease path for bespoke genetic treatments

Asbestos ban is immediate, but health effects will linger for decades

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

knowledge

Wikipedia

hotspot

Wikipedia